Cannabis Indica

The validity of the Hospital Anxiety and Depression Scale: an updated literature review

I Bjelland, AA Dahl, TT Haug, D Neckelmann - Journal of psychosomatic …, 2002 - Elsevier
Objective: To review the literature of the validity of the Hospital Anxiety and Depression
Scale (HADS). Method: A review of the 747 identified papers that used HADS was …

Compassionate mind training for people with high shame and self‐criticism: Overview and pilot study of a group therapy approach

P Gilbert, S Procter - … : An International Journal of Theory & …, 2006 - Wiley Online Library
Compassionate mind training (CMT) was developed for people with high shame and self‐
criticism, whose problems tend to be chronic, and who find self‐warmth and self‐acceptance …

Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population

A Mykletun, E Stordal, AA Dahl - The British journal of psychiatry, 2001 - cambridge.org
BackgroundThe Hospital Anxiety and Depression (HAD) rating scale is a commonly used
questionnaire. Former studies have given inconsistent results as to the psychometric …

Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence

S Simard, J Savard - Supportive care in cancer, 2009 - Springer
Background Despite the fact that the fear of cancer recurrence is to varying degrees almost
universal in cancer survivors, there is a lack of validated multidimensional instruments to …

COVID-19 pandemic stressors and psychological symptoms in breast cancer patients

V Massicotte, H Ivers, J Savard - Current Oncology, 2021 - mdpi.com
Background. The current Coronavirus disease 2019 (COVID-19) pandemic is a highly
stressful event that may lead to significant psychological symptoms, particularly in cancer …

Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects

J Savard, S Simard, H Ivers, CM Morin - Journal of Clinical Oncology, 2005 - ascopubs.org
Purpose Chronic insomnia is highly prevalent in cancer patients. Cognitive-behavioral
therapy (CBT) is considered the treatment of choice for chronic primary insomnia. However …

Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample

I Michopoulos, A Douzenis, C Kalkavoura… - Annals of general …, 2008 - Springer
Abstract Background The Hospital Anxiety and Depression Scale (HADS) has been used in
several languages to assess anxiety and depression in general hospital patients with good …

Stability versus change, dependability versus error: Issues in the assessment of personality over time

D Watson - Journal of Research in Personality, 2004 - Elsevier
Temporal instability can reflect either true psychological change or measurement error. I
offer several recommendations to improve stability research and enhance the ability to …

Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine-or efavirenz-based antiretroviral therapy

JJ Parienti, V Massari, D Descamps… - Clinical Infectious …, 2004 - academic.oup.com
Resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) increases with the
wider use of this class of antiretroviral therapy. The association between adherence and …

[PDF][PDF] Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period

J Savard, J Villa, H Ivers, S Simard, CM Morin - J clin oncol, 2009 - academia.edu
Results At T1, 28.5% of the patients met the diagnostic criteria for an insomnia syndrome,
and 31.0% had insomnia symptoms; these rates decreased to 26.2% and 22.2 …

Leave a Reply